Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma

Yang Ying; Wang Jin; Xu Shihai; Shi Fei; Shan Aijun

doi:10.1515/tnsci-2021-0004

Translational Neuroscience (Feb 2021)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma

Yang Ying,
Wang Jin,
Xu Shihai,
Shi Fei,
Shan Aijun

Affiliations

Yang Ying: Department of Pediatrics, Futian Women and Children Health Institute, Shenzhen 518045, China
Wang Jin: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China
Xu Shihai: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China
Shi Fei: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China
Shan Aijun: Department of Emergency, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China

DOI: https://doi.org/10.1515/tnsci-2021-0004
Journal volume & issue: Vol. 12, no. 1
pp. 67 – 75

Abstract

Read online

Calumenin (CALU) has been reported to be associated with invasiveness and metastasis in some malignancies. However, in glioma, the role of CALU remains unclear.

Published in Translational Neuroscience

ISSN: 2081-6936 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.degruyter.com/view/j/tnsci

About the journal

Abstract

Keywords